Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan

Gynecologic Oncology

Volumn 138, Issue 1, 2015, Pages 147-153

  Tseng, Chin Hsiao ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Diabetes; Dose response; Endometrial cancer; Epidemiology; Metformin; Taiwan

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; INSULIN; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA; TICLOPIDINE; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHINESE; COHORT ANALYSIS; DIABETIC PATIENT; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; TAIWAN; TREATMENT DURATION; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; ENDOMETRIAL NEOPLASMS; INCIDENCE; PROPORTIONAL HAZARDS MODEL;

CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; METFORMIN; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84931570550     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.03.059     Document Type: Article

References (39)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
2. C.J. Chiang, Y.C. Chen, C.J. Chen, and S.L. You Lai MS; Taiwan cancer registry task force. Cancer trends in Taiwan Jpn. J. Clin. Oncol. 40 2010 897 904
3. V.W. Setiawan, H.P. Yang, M.C. Pike, S.E. McCann, H. Yu, and Y.B. Xiang Type I and II endometrial cancers: have they different risk factors? J. Clin. Oncol. 31 2013 2607 2618
4. S.G.O. Clinical Practice Endometrial Cancer Working Group, Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye A, et al. for the Society of Gynecologic Oncology Clinical Practice Committee. Endometrial cancer: a review and current management strategies: Part I Gynecol. Oncol. 134 2014 385 392
5. C.C. Imes, and L.E. Burke The obesity epidemic: the United States as a cautionary tale for the rest of the world Curr. Epidemiol. Rep. 1 2014 82 88
6. K.K. Ward, A.M. Roncancio, N.R. Shah, M.A. Davis, C.C. Saenz, and M.T. McHale The risk of uterine malignancy is linearly associated with body mass index in a cohort of US women Am. J. Obstet. Gynecol. 209 2013 (579.e1-5)
7. M. Franciosi, G. Lucisano, E. Lapice, G.F. Strippoli, F. Pellegrini, and A. Nicolucci Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review PLoS ONE 8 2013 e71583
8. A. Ferrara, J.D. Lewis, C.P. Quesenberry Jr., T. Peng, B.L. Strom, and S.K. Van Den Eeden Cohort study of pioglitazone and cancer incidence in patients with diabetes Diabetes Care 34 2011 923 929
9. P.D. Home, S.E. Kahn, N.P. Jones, D. Noronha, H. Beck-Nielsen, and G. Viberti ADOPT study group; RECORD steering committee. Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials Diabetologia 53 2010 1838 1845
10. C. Becker, S.S. Jick, C.R. Meier, and M. Bodmer Metformin and the risk of endometrial cancer: a case-control analysis Gynecol. Oncol. 129 2013 565 569
11. E.M. Ko, T. Stürmer, J.L. Hong, W.C. Castillo, V. Bae-Jump, and M.J. Funk Metformin and the risk of endometrial cancer: a population-based cohort study Gynecol. Oncol. 136 2015 341 347
12. T. Gerhard Bias: considerations for research practice Am. J. Health Syst. Pharm. 65 2008 2159 2168
13. B.H. Stricker, and T. Stijnen Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies Eur. J. Epidemiol. 25 2010 245 251
14. S. Suissa Immortal time bias in pharmaco-epidemiology Am. J. Epidemiol. 167 2008 492 499
15. The expert committee on the diagnosis and classification of diabetes mellitus: report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 20 1997 1183 1197
16. C.H. Tseng Pioglitazone does not affect the risk of ovarian cancer: analysis of a nationwide reimbursement database in Taiwan Gynecol. Oncol. 131 2013 135 139
17. C.H. Tseng Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes Ann. Med. 45 2013 539 544
18. C.H. Tseng Pioglitazone and bladder cancer: a population-based study of Taiwanese Diabetes Care 35 2012 278 280
19. R.B. D'Agostino Jr. Propensity scores in cardiovascular research Circulation 115 2007 2340 2343
20. B.H. Stricker, and T. Stijnen Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies Eur. J. Epidemiol. 25 2010 245 251
21. C.H. Tseng Thyroid cancer risk is not increased in diabetic patients PLoS ONE 7 2012 e53096
22. C.H. Tseng Pioglitazone does not affect the risk of kidney cancer in patients with type 2 diabetes Metabolism 63 2014 1049 1055
23. O. Karlstad, J. Starup-Linde, P. Vestergaard, V. Hjellvik, M.T. Bazelier, and M.K. Schmidt Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies Curr. Drug Saf. 8 2013 333 348
24. K. Shikata, T. Ninomiya, and Y. Kiyohara Diabetes mellitus and cancer risk: review of the epidemiological evidence Cancer Sci. 104 2013 9 14
25. Cancer Research UK Uterine (womb) Cancer Incidence Statistics http://www.cancerresearchuk.org/cancer-info/cancerstats/types/uterus/incidence/uk-uterus-cancer-incidence-statistics (date last accessed: 5 March 2015)
26. Demographics of the United States http://en.wikipedia.org/wiki/Demographics-of-the-United-States#cite-note-c2010-47 (date last accessed: 5 March 2015)
27. The Population of Taiwan (in Chinese) http://zh.wikipedia.org/wiki/%E8%87%BA%E7%81%A3%E4%BA%BA%E5%8F%A3 (date last accessed: 5 March 2015)
28. N.S. Nevadunsky, A. Van Arsdale, H.D. Strickler, A. Moadel, G. Kaur, and M. Frimer Metformin use and endometrial cancer survival Gynecol. Oncol. 132 2014 236 240
29. H. Nasri, and M. Rafieian-Kopaei Metformin: current knowledge J. Res. Med. Sci. 19 2014 658 664
30. M. Niafar, F. Hai, J. Porhomayon, and N.D. Nader The role of metformin on vitamin B12 deficiency: a meta-analysis review Intern. Emerg. Med. 10 2015 93 102
31. E.M. Moore, A.G. Mander, D. Ames, M.A. Kotowicz, R.P. Carne, and H. Brodaty AIBL Investigators. Increased risk of cognitive impairment in patients with diabetes is associated with metformin Diabetes Care 36 2013 2981 2987
32. C.H. Tseng Body mass index and blood pressure in adult type 2 diabetic patients in Taiwan Circ. J. 71 2007 1749 1754
33. L.S. Cook, H.E. Nelson, C.A. Stidley, Y. Dong, P.J. Round, and E.K. Amankwah Endometrial cancer and a family history of cancer Gynecol. Oncol. 130 2013 334 339
34. T. Dorjgochoo, Y.B. Xiang, J. Long, J. Shi, S. Deming, and W.H. Xu Association of genetic markers in the BCL-2 family of apoptosis-related genes with endometrial cancer risk in a Chinese population PLoS ONE 8 2013 e60915
35. C.M. Dieli-Conwright, H. Ma, J.V. Lacey Jr., K.D. Henderson, S. Neuhausen, and P.L. Horn-Ross Long-term and baseline recreational physical activity and risk of endometrial cancer: the California Teachers Study Br. J. Cancer 109 2013 761 768
36. A. Giri, S.R. Sturgeon, N. Luisi, E. Bertone-Johnson, R. Balasubramanian, and K.W. Reeves Caffeinated coffee, decaffeinated coffee and endometrial cancer risk: a prospective cohort study among US postmenopausal women Nutrients 3 2011 937 950
37. K. Sak Site-specific anticancer effects of dietary flavonoid quercetin Nutr. Cancer 66 2014 177 193
38. L. Dossus, A. Lukanova, S. Rinaldi, N. Allen, A.E. Cust, and S. Becker Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort - a factor analysis Am. J. Epidemiol. 177 2013 787 799
39. M.N. Shafiee, G. Khan, R. Ariffin, J. Abu, C. Chapman, and S. Deen Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help? Gynecol. Oncol. 132 2014 248 253